High-Flow Nasal Cannula Market Updated Strategies 2027 | Salter Labs, TNI Medical Ag, Vapotherm, Mek-Ics Co., Fisher & Paykel Healthcare

The global high flow nasal cannula market, based on component, has been segmented into air oxygen blender, nasal cannula, heated inspiratory circuit, and active humidifier. In 2018, the active humidifier segment held the largest share of the market. Moreover, the segment is also expected to register the highest CAGR in the market during the forecast period.

The global high flow nasal cannula market is anticipated to reach US$ 11,198.78 Mn in 2027 from US$ 4,390.74 Mn in 2018. The market is anticipated to grow with a CAGR of 11.1% from 2019-2027.

Get sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPMD00002292/?openpr-10144

The report provides trends prevailing in the global high flow nasal cannula market and the factors driving the market along with those that act as hindrances. Among the regions, Asia Pacific is anticipated to witness significant growth during the forecast period. One of the factors anticipated to drive the growth of the high flow nasal cannula market in the Asia Pacific includes rising development in the healthcare sector. Also, the presence of associations and organizations working towards providing respiratory care to patients is expected to offer significant growth opportunities during the forecast period.

Leading companies operating in the high-flow nasal cannula market are Great Group Medical Co., Ltd., Salter Labs, Fisher and Paykel Healthcare Limited, TNI Medical AG, MEK-ICS Co., Ltd. Flexi Care Medical Limited, Vapotherm, Teleflex Incorporated, Resmed, Inc., Hamilton Medical among others.

COPD and asthma are senescence condition, which leads to gradual complications. Asthma in older adults is a critical condition that often goes unnoticed, as per the Asthma and Allergy Foundation of America (AAFA). According to the Office of Disease Prevention and Health Promotion (ODPHP), approximately 23 million people in the U.S. have some form of asthma, most of which include the older population. Older people with asthma often need high doses of medication, in spite of mild asthma attacks. Hence, they are more likely to suffer from respiratory failure much faster as compared to the younger population. Also, COPD can appear at any age. However, it is more prevalent in the older population and can be fatal. The aging population is growing exponentially worldwide.

Moreover, the Centers for Disease Control and Prevention (CDC) reported, approximately 19 million adults in the United States (18 years of age or above) are currently suffering from asthma, which accounts for almost 7.7% of the total adult population. Whereas, about 6.2 million patients below 18 years of age have asthma, which accounts for 8.4% of the total children population. Also, according to the WHO estimates published during December 2016, there were around 383,000 deaths due to asthma in 2015.

Buy Complete Report @ https://www.theinsightpartners.com/buy/TIPMD00002292/?openpr-10144

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.